文献速递妇科

根治性子宫切除术及盆腔淋巴结清扫联合腹主动脉旁淋巴结取样或清扫后淋巴结阳性宫颈癌患者远处复发的术后评分系统

A postoperative scoring system for distant recurrence in node-positive cervical cancer patients after radical hysterectomy and pelvic lymph node dissection with para-aortic lymph node sampling or dissection.
PubMed 文献 · Gynecol Oncol · 2017-01-17

回顾性分析223例IA2~IIB期淋巴结阳性宫颈癌患者,根治术后远处转移54例(24.2%)。组织学类型、阳性淋巴结数和手术分期为远处复发独立危险因素,据此建立评分系统,一致性指数0.753,内部验证C统计量0.777。

要点

  • 组织学类型、阳性淋巴结数、手术分期是远处复发独立危险因素
  • 评分系统一致性指数0.753,内部验证C统计量0.777
  • 该评分系统用于识别需全身控制远处微转移的患者群

核心结论

  • 建立了可预测淋巴结阳性宫颈癌根治术后远处复发风险的评分系统。
  • 该评分系统用于识别需要全身控制远处微转移的患者群,该群体适合同步放化疗后巩固化疗。

研究设计与样本

  • 回顾性分析2001年2月至2012年12月在Asan Medical Center根治术后证实淋巴结转移的IA2~IIB期宫颈癌患者,共299例,其中72例(24.1%)仅行盆腔淋巴结清扫,227例(75.9%)行盆腔淋巴结清扫联合腹主动脉旁淋巴结取样或清扫。
  • 排除4例诊断为小细胞癌者,最终分析223例的临床病理资料。
  • 远处复发定义为盆腔放疗野以外的部位复发。

主要发现

  • 223例患者中,平均阳性淋巴结数为4.46,远处转移54例(24.2%)。
  • Cox比例风险模型多因素分析显示,组织学类型(腺癌HR=3.031,P≤0.001;腺鳞癌HR=2.302,P=0.066)、阳性淋巴结数(HR=1.077,P≤0.001)和手术分期(HR=1.264,P=0.022)为宫颈癌远处复发的独立危险因素。
  • 评分系统一致性指数为0.753;内部验证集C统计量为0.777;Hosmer-Lemeshow检验卡方为0.650,P值为0.723。

关键数值与推荐

  • 腺癌HR=3.031(P≤0.001),腺鳞癌HR=2.302(P=0.066),阳性淋巴结数HR=1.077(P≤0.001),手术分期HR=1.264(P=0.022)。
  • 评分系统一致性指数0.753,内部验证C统计量0.777,Hosmer-Lemeshow检验卡方0.650、P=0.723。

临床怎么用

  • 作者认为该评分系统可用于识别需要全身控制远处微转移的患者群,该群体适合同步放化疗后巩固化疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify risk factors for distant recurrence in node-positive cervical cancer patients who underwent radical hysterectomy and pelvic lymph node dissection (PLND) with para-aortic lymph node sampling (PALNS) or para-aortic lymph node dissection (PALND). METHODS: A total of 299 patients in whom lymph node metastasis was confirmed after radical surgery at Asan Medical Center for stage IA2 to IIB cervical cancer from February 2001 to December 2012 were identified. In all, 72 (24.1%) patients underwent PLND only and 227 (75.9%) underwent PLND with PALNS or PALND. Four patients were excluded due to diagnosed with small cell carcinoma. The clinicopathologic data of 223 patients were retrospectively analyzed. Distant recurrence was defined as recurrence at a site over the pelvic radiation field. RESULTS: Among all 223 study patients, the mean number of positive lymph nodes was 4.46. There were 54 (24.2%) patients with distant metastasis. Multivariate analyses using the Cox proportional hazards model showed that histologic types (HR=3.031, P≤0.001 for adenocarcinoma, HR=2.302, P=0.066 for adenosquamous carcinoma), number of positive lymph nodes (HR=1.077, P≤0.001), and surgical stage (HR=1.264, P=0.022) were independent risk factors for distant recurrence of cervical cancer. A scoring system for the prediction of distant recurrence was generated by incorporating these factors and showed good discrimination and calibration (concordance index of 0.753). In an internal validation set, this scoring system showed good discrimination with a C-statistics of 0.777. According to the Hosmer-Lemeshow test, the chi-square was 0.650 and the P-value was 0.723. CONCLUSIONS: We have developed a robust scoring system that can predict the risk of distant recurrence in node-positive cervical cancer patients after radical operation. This scoring system was used to identify a group of patients who required systemic control of distant micrometastasis. This group of patients is an appropriate target for consolidation chemotherapy after concurrent chemoradiation therapy.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Lee YJ, Kim DY, Lee SW, et al. A postoperative scoring system for distant recurrence in node-positive cervical cancer patients after radical hysterectomy and pelvic lymph node dissection with para-aortic lymph node sampling or dissection. Gynecol Oncol. 2017. PMID: 28108027. doi:10.1016/j.ygyno.2017.01.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。